Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Evaluation of targeting autophagy for the treatment of malignant rhabdoid tumours.
Cancer Treat Res Commun. 2022;32:100584. doi: 10.1016/j.ctarc.2022.100584. Epub 2022 Jun 3.
Cancer Treat Res Commun. 2022.
PMID: 35679755
Free article.
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation.
Saraswati AP, Relitti N, Brindisi M, Osko JD, Chemi G, Federico S, Grillo A, Brogi S, McCabe NH, Turkington RC, Ibrahim O, O'Sullivan J, Lamponi S, Ghanim M, Kelly VP, Zisterer D, Amet R, Hannon Barroeta P, Vanni F, Ulivieri C, Herp D, Sarno F, Di Costanzo A, Saccoccia F, Ruberti G, Jung M, Altucci L, Gemma S, Butini S, Christianson DW, Campiani G.
Saraswati AP, et al. Among authors: hannon barroeta p.
ACS Med Chem Lett. 2020 Sep 29;11(11):2268-2276. doi: 10.1021/acsmedchemlett.0c00395. eCollection 2020 Nov 12.
ACS Med Chem Lett. 2020.
PMID: 33214839
Free PMC article.
Item in Clipboard
The role of the Nrf2/GSH antioxidant system in cisplatin resistance in malignant rhabdoid tumours.
Hannon Barroeta P, O'Sullivan MJ, Zisterer DM.
Hannon Barroeta P, et al.
J Cancer Res Clin Oncol. 2023 Sep;149(11):8379-8391. doi: 10.1007/s00432-023-04734-x. Epub 2023 Apr 20.
J Cancer Res Clin Oncol. 2023.
PMID: 37079050
Free PMC article.
Item in Clipboard
Synthesis by diastereomeric resolution, biochemical evaluation and molecular modelling of chiral 3-hydroxyl b-lactam microtubule-targeting agents for the treatment of triple negative breast and chemoresistant colorectal cancers.
McLoughlin EC, Twamley B, O'Brien JE, Hannon Barroeta P, Zisterer DM, Meegan MJ, O'Boyle NM.
McLoughlin EC, et al. Among authors: hannon barroeta p.
Bioorg Chem. 2023 Dec;141:106877. doi: 10.1016/j.bioorg.2023.106877. Epub 2023 Sep 30.
Bioorg Chem. 2023.
PMID: 37804699
Free article.
Item in Clipboard
Cisplatin induces autophagy-associated apoptosis in human oral squamous cell carcinoma (OSCC) mediated in part through reactive oxygen species.
Magnano S, Hannon Barroeta P, Duffy R, O'Sullivan J, Zisterer DM.
Magnano S, et al. Among authors: hannon barroeta p.
Toxicol Appl Pharmacol. 2021 Sep 15;427:115646. doi: 10.1016/j.taap.2021.115646. Epub 2021 Jul 16.
Toxicol Appl Pharmacol. 2021.
PMID: 34274415
Free article.
Item in Clipboard
Targeting inhibitor of apoptosis proteins (IAPs) enhances susceptibility of oral squamous carcinoma cells to cisplatin.
Gao T, Magnano S, Rynne A, O'Kane L, Barroeta PH, Zisterer DM.
Gao T, et al. Among authors: barroeta ph.
Exp Cell Res. 2024 Apr 1;437(1):113995. doi: 10.1016/j.yexcr.2024.113995. Epub 2024 Mar 13.
Exp Cell Res. 2024.
PMID: 38490621
Free article.
Item in Clipboard
Cite
Cite